None of the 29 investors followed here reported a position in RLXXF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a RLXXF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.1 | -1.1 | -4.6 | 11.5 | -12.2 | -2.8 | 12.2 | 3.0 | -8.6 | 9.4 | −9.8% | ||
| 2025 | 13.2 | -5.5 | 7.9 | 8.2 | -1.2 | 1.4 | -3.9 | -11.5 | 1.7 | -7.4 | -8.2 | -0.4 | −8.3% |
| 2024 | 5.4 | 4.1 | 1.9 | -2.0 | -0.7 | 8.9 | 1.2 | 0.7 | 0.7 | -6.0 | 6.2 | -7.4 | +12.5% |
| 2023 | 5.7 | 2.2 | 7.8 | 2.3 | -6.6 | 7.6 | 1.2 | -2.2 | 2.9 | 2.5 | 13.5 | -1.2 | +40.0% |
| 2022 | -6.8 | -1.0 | 3.0 | -8.6 | 0.9 | -7.1 | 8.0 | -9.8 | -7.3 | 9.7 | 4.6 | 0.3 | −15.5% |
| 2021 | 1.6 | -5.4 | 6.9 | 3.3 | 0.8 | 0.6 | 12.0 | 1.5 | -3.0 | 6.6 | 0.2 | 4.9 | +33.1% |
| 2020 | 6.9 | -11.0 | -9.6 | 6.9 | 1.3 | 2.4 | -10.4 | 9.5 | -2.6 | -12.8 | 19.3 | 5.8 | +0.2% |
| 2019 | 6.7 | 5.8 | -8.1 | 7.5 | 1.0 | 7.5 | -3.7 | 0.6 | -2.3 | 3.4 | 0.0 | 2.9 | +22.0% |
| 2018 | -6.8 | -4.5 | -1.3 | 3.9 | 2.3 | -3.9 | 5.1 | 1.3 | -4.7 | -9.2 | 6.5 | -1.5 | −13.2% |
| 2017 | -0.5 | 7.1 | 4.8 | 4.6 | -0.5 | 6.4 | 0.0 | -0.7 | 3.3 | 0.0 | 6.0 | -0.7 | +33.7% |
| 2016 | -7.8 | 3.5 | 4.8 | -2.8 | 5.7 | -5.9 | 9.2 | 1.3 | -0.3 | -8.9 | -2.3 | 2.0 | −3.1% |
| 2015 | 6.1 | 4.0 | 1.4 | -1.4 | +10.4% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Relx Plc | Buy Back at price 33.47 per share. | 149K | $4.99M |
| Sep 30, 2026 | Relx Plc | Buy Back at price 32.77 per share. | 148.5K | $4.87M |
| Sep 29, 2026 | Relx Plc | Buy Back at price 33.00 per share. | 149.1K | $4.92M |
| Sep 28, 2026 | Relx Plc | Buy Back at price 33.09 per share. | 148.7K | $4.92M |
| Sep 27, 2026 | Relx Plc | Buy Back at price 33.18 per share. | 151.6K | $5.03M |
| Sep 24, 2026 | Relx Plc | Buy Back at price 33.35 per share. | 149.3K | $4.98M |
| Sep 23, 2026 | Relx Plc | Buy Back at price 33.22 per share. | 149.8K | $4.98M |
| Sep 22, 2026 | Relx Plc | Buy Back at price 32.79 per share. | 151.3K | $4.96M |
| Sep 21, 2026 | Relx Plc | Buy Back at price 33.15 per share. | 151.3K | $5.01M |
| Sep 20, 2026 | Relx Plc | Buy Back at price 33.23 per share. | 150K | $4.99M |
| Sep 17, 2026 | Relx Plc | Buy Back at price 33.84 per share. | 149.2K | $5.05M |
| Sep 16, 2026 | Relx Plc | Buy Back at price 34.27 per share. | 147.4K | $5.05M |
| Sep 15, 2026 | Relx Plc | Buy Back at price 33.67 per share. | 147.4K | $4.96M |
| Sep 14, 2026 | Relx Plc | Buy Back at price 34.10 per share. | 148.4K | $5.06M |
| Sep 13, 2026 | Relx Plc | Buy Back at price 35.05 per share. | 144.4K | $5.06M |
| Sep 10, 2026 | Relx Plc | Buy Back at price 33.40 per share. | 151.6K | $5.07M |
| Sep 9, 2026 | Relx Plc | Buy Back at price 33.96 per share. | 148.6K | $5.05M |
| Sep 8, 2026 | Relx Plc | Buy Back at price 34.32 per share. | 147.2K | $5.05M |
| Sep 7, 2026 | Relx Plc | Buy Back at price 34.78 per share. | 146.4K | $5.09M |
| Sep 6, 2026 | Relx Plc | Buy Back at price 34.86 per share. | 142.8K | $4.98M |
No analyst coverage for this instrument.
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.